This study presents a thorough and up‐to‐date meta‐analysis of clinical studies aimed at evaluating the safety and effectiveness of sacubitril‐valsartan in comparison to RAAS inhibitors (ACE inhibitors or ARBs) as standalone treatments for patients diagnosed with heart failure. Here, ACE is linked to heart failure.